PUREfi Wealth’s AstraZeneca AZN Stock Holding History

PUREfi Wealth’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$339K	Buy	1,788 +510	+40%	+$95.9K	0.19%	142
2026 Q1	$252K	Buy	+1,278	New	+$246K	0.17%	159

Other funds holding AZN

Evelyn Partners London $46.9B AUM

Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

PUREfi Wealth's AZN Position: Q2 2026 in Review

PUREfi Wealth increased its AstraZeneca (AZN) stake by 40% in Q2 2026, buying an estimated $95.9K and bringing the position to 1,788 shares worth $339K. The position accounts for 0.19% of the portfolio, ranked #142.

PUREfi Wealth first reported a position in AZN in Q1 2026 and has held it in 2 quarters since. 1,502 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

PUREfi Wealth held 1,788 shares of AstraZeneca worth $339K as of Q2 2026.
PUREfi Wealth bought 510 AstraZeneca shares in Q2 2026, an estimated $95.9K.
AstraZeneca made up 0.19% of PUREfi Wealth's portfolio in Q2 2026, its #142 holding.
PUREfi Wealth first reported a position in AstraZeneca in Q1 2026 and has held it in 2 quarters since.
1,502 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on PUREfi Wealth's 13F filing for Q2 2026, filed 27 Jul 2026.